European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS)
European Stroke Journal · 01.12.2023 · 8 (4) · 842-879
DOI: 10.1177/23969873231190431 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Stroke Journal, online erschienen am 01.12.2023. Verfasst von Rosario Pascarella und 13 weiteren Autor:innen. Beteiligte Einrichtung: Neuroradiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Stroke, Brain. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
The European Stroke Organisation (ESO) guideline on Primary Angiitis of the Central Nervous System (PACNS), developed according to ESO standard operating procedures (SOP) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, was elaborated to assist clinicians in the diagnostic and treatment pathway of patients with PACNS in their decision making. A working group involving vascular neurologists, neuroradiologists, rheumatologists, a neuropathologist and a methodologist identified 17 relevant clinical questions; these were addressed according to the patient/population, intervention, comparison and outcomes (PICO) framework and systematic literature reviews were performed. Notably, each PICO was addressed with respect to large vessel (LV)-PACNS and small vessel (SV)-PACNS. Data to answer many questions were scarce or lacking and the quality of evidence was very low overall, so, for some PICOs, the recommendations reflect the ongoing uncertainty. When the absence of sufficient evidence precluded recommendations, Expert Consensus Statements were formulated. In some cases, this applied to interventions in the diagnosis and treatment of PACNS which are embedded widely in clinical practice, for example patterns of cerebrospinal fluid (CSF) and Magnetic Resonance Imaging (MRI) abnormalities. CSF analysis for hyperproteinorrachia and pleocytosis does not have evidence supporting their use as diagnostic tools. The working group recommended that caution is employed in the interpretation of non-invasive vascular imaging due to lack of validation and the different sensitivities in comparison with digital subtraction angiography (DSA) and histopathological analyses. Moreover, there is not a neuroimaging pattern specific for PACNS and neurovascular issues are largely underreported in PACNS patients. The group’s recommendations on induction and maintenance of treatment and for primary or secondary prevention of vascular events also reflect uncertainty due to lack of evidence. Being uncertain the role and practical usefulness of current diagnostic criteria and being not comparable the main treatment strategies, it is suggested to have a multidisciplinary team approach in an expert center during both work up and management of patients with suspected PACNS. Highlighting the limitations of the currently accepted diagnostic criteria, we hope to facilitate the design of multicenter, prospective clinical studies and trials. A standardization of neuroimaging techniques and reporting to improve the level of evidence underpinning interventions employed in the diagnosis and management of PACNS. We anticipate that this guideline, the first comprehensive European guideline on PACNS management using GRADE methodology, will assist clinicians to choose the most effective management strategy for PACNS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroradiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.
- Neuroradiology - Diagnostic and Interventional Neuroradiology, CIC-IT 1415, INSERM 1253 iBrain, Tours University Hospital, Centre Val de Loire Region, France.
- Service de Médecine Interne, CHU de Caen, Avenue de la Côte de Nacre, Caen, France; Université Caen Normandie, Caen, France.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- Stroke Unit, Metropolitan Hospital, Ethnarchou Makariou 9, Piraeus, Greece.
ORCID-Profile: Rosario Pascarella, Hubert De Boysson, Odysseas Kargiotis, Thanh N Nguyen, Claire M Rice, Daniel Strbian, Marialuisa Zedde
Zitieren
APA
Pascarella, R., Antonenko, K., Boulouis, G., De Boysson, H., Giannini, C., Heldner, M. R., Kargiotis, O., Nguyen, T. N., Rice, C. M., Salvarani, C., Schmidt-Pogoda, A., Strbian, D., Hussain, S., & Zedde, M. (2023). European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS). European Stroke Journal, 8(4), 842-879. https://doi.org/10.1177/23969873231190431
Vancouver
Pascarella R, Antonenko K, Boulouis G, De Boysson H, Giannini C, Heldner MR, et al. European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS). European Stroke Journal. 2023;8(4):842-879. doi:10.1177/23969873231190431
BibTeX
@article{Pascarella2023,
author = {Pascarella, Rosario and Antonenko, Katherina and Boulouis, Grégoire and De Boysson, Hubert and Giannini, Caterina and Heldner, Mirjam R and Kargiotis, Odysseas and Nguyen, Thanh N and Rice, Claire M and Salvarani, Carlo and Schmidt-Pogoda, Antje and Strbian, Daniel and Hussain, Salman and Zedde, Marialuisa},
title = {European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS)},
journal = {European Stroke Journal},
year = {2023},
volume = {8},
number = {4},
pages = {842--879},
doi = {10.1177/23969873231190431}
}
EUVIMED